Evidence map›Paper›PMID 18518925›Full record

ArticleGenes, brain, and behavior2008

Genetic susceptibility to heroin addiction: a candidate gene association study.

O Levran, D Londono, K O'Hara, D A Nielsen, E Peles, J Rotrosen, P Casadonte, S Linzy, M Randesi, J Ott and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes, brain, and behavior, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 2 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  9. Review
  10. Review
  11. Article
  12. Review
  13. Genetic and Epigenetic Approaches to Opioid Use Disorder.Expert reviews in molecular medicine · 2025
    Review
  14. Article
  15. Frontiers in pharmacology · 2025
    Article
  16. Biochemical Diagnosis in Substance and Non-substance Addiction.Advances in experimental medicine and biology · 2025
    Review
  17. Article
  18. SNP analysis of stress-related genes reveals significant correlations with drug addiction in Jordan.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

O LevranThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA. levrano@rockefeller.edu
D Londono
K O'Hara
D A Nielsen
E Peles
J Rotrosen
P Casadonte
S Linzy
M Randesi
J Ott
M Adelson
M J Kreek
Rockefeller University · USChinese Academy of Sciences · CNVA NY Harbor Healthcare System · US

Funding

TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTHUL1RR024143 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2006 to 2011
$49.1M
ULTRASTUCTURE, RECEPTORS, AND GENE EXPRESSIONP60DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2002 to 2012
$30.6M
Addictive Drugs-Pharmacology &PhysiologyK05DA000049 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1985 to 2007
$1.0M
NCRR NIH HHS UL1 RR024143NCRR NIH HHS UL1-RR024143NIDA NIH HHS K05 DA000049NIDA NIH HHS P60 DA005130PHS HHS P60-05130PHS HHS R01-44292
6 · The paper itself

Abstract

Heroin addiction is a chronic complex disease with a substantial genetic contribution. This study was designed to identify genetic variants that are associated with susceptibility to develop heroin addiction by analyzing 1350 variants in 130 candidate genes. All subjects had Caucasian ancestry. The sample consisted of 412 former severe heroin addicts in methadone treatment, and 184 healthy controls with no history of drug abuse. Nine variants, in six genes, showed the lowest nominal P values in the association tests (P < 0.01). These variants were in noncoding regions of the genes encoding the mu (OPRM1; rs510769 and rs3778151), kappa (OPRK1; rs6473797) and delta (OPRD1; rs2236861, rs2236857 and rs3766951) opioid receptors; the neuropeptide galanin (GAL; rs694066); the serotonin receptor subtype 3B (HTR3B; rs3758987) and the casein kinase 1 isoform epsilon (CSNK1E; rs1534891). Several haplotypes and multilocus genotype patterns showed nominally significant associations (e.g. OPRM1; P = 0.0006 and CSNK1E; P = 0.0007). Analysis of a combined effect of OPRM1 and OPRD1 showed that rs510769 and rs2236861 increase the risk of heroin addiction (P = 0.0005). None of these associations remained significant after adjustment for multiple testing. This study suggests the involvement of several genes and variants in heroin addiction, which is worthy of future study.

Indexed as

Casein Kinase 1 epsilonDNAFemaleGalaninGenetic MarkersGenetic Predisposition to DiseaseGenotypeHaplotypesHeroin DependenceHumansLinkage DisequilibriumMaleMultigene FamilyPhenotypePolymorphism, Single NucleotideReceptors, Opioid, deltaCasein Kinase 1 epsilonDNAGalaninGenetic MarkersHTR3B protein, humanReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muReceptors, SerotoninReceptors, Serotonin, 5-HT3

Identifiers

PMID18518925
PMCPMC2885890
OpenAlexW2083332683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.